Figure 5.
Figure 5. Skin graft survival after busulfan. (A) Skin graft survival (EGFP.Tg and B10.A) performed at 17 weeks after BMT in 5 female B6 recipients of busulfan (BU, 2 × 10 mg/kg) and BMCs from B6-EGFP.Tg or B6-Ly5.1 donor mice. (B) Skin graft survival (EGFP.Tg and B6-H2b) performed at 12 weeks after BMT in male B6 recipients of saline (4 mice) or BX (2 × 10 mg/kg) (5 mice) and BMCs from B6-EGFP.Tg donor mice.

Skin graft survival after busulfan. (A) Skin graft survival (EGFP.Tg and B10.A) performed at 17 weeks after BMT in 5 female B6 recipients of busulfan (BU, 2 × 10 mg/kg) and BMCs from B6-EGFP.Tg or B6-Ly5.1 donor mice. (B) Skin graft survival (EGFP.Tg and B6-H2b) performed at 12 weeks after BMT in male B6 recipients of saline (4 mice) or BX (2 × 10 mg/kg) (5 mice) and BMCs from B6-EGFP.Tg donor mice.

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal